Drug profile · INN
flavoxate hydrochloride
FLAVOXATE HYDROCHLORIDE
flavoxate hydrochloride (FLAVOXATE HYDROCHLORIDE) is a phosphodiesterase 4 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — flavoxate hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
flavoxate hydrochloride (FLAVOXATE HYDROCHLORIDE) is a phosphodiesterase 4 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Phosphodiesterase 4 inhibitor
Primary target: Phosphodiesterase 4
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is flavoxate hydrochloride?
flavoxate hydrochloride (FLAVOXATE HYDROCHLORIDE) is a phosphodiesterase 4 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for flavoxate hydrochloride?
FLAVOXATE HYDROCHLORIDE is a marketed brand name for flavoxate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of flavoxate hydrochloride?
flavoxate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.